The Leading TGF-ß for Immuno-Oncology Summit Returns Exclusively Dedicated to Exploring the Role of TGF-ß in Cancer Therapeutics It is evident that TGF-ß holds exciting therapeutic promise to IO drug developers but with the complexity of this target, there are still many hurdles to overcome.
25-27 January 2022